A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension (Q42727514)
Jump to navigation
Jump to search
scientific article published on September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension |
scientific article published on September 2011 |
Statements
1 reference
A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension (English)
1 reference
Ronald A Schachar
1 reference
Susan Raber
1 reference
Rachel Courtney
1 reference
Min Zhang
1 reference
1 September 2011
1 reference
1 reference
36
1 reference
9
1 reference
809-817
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference